Ibandronate reduces endogenous reactive oxygen species levels in cultured prostate cancer and endothelial cells

MeSH terms

• Bone Density Conservation Agents / pharmacology*
• Cell Line, Tumor
• Cells, Cultured
• Diphosphonates / pharmacology*
• Dose-Response Relationship, Drug
• Endothelial Cells / drug effects*
• Endothelial Cells / metabolism
• Endothelium, Vascular / drug effects
• Endothelium, Vascular / metabolism
• Fluoresceins / metabolism
• Fluorescent Dyes / metabolism
• Humans
• Ibandronic Acid
• Male
• Oxidation-Reduction
• Prostatic Neoplasms / drug therapy*
• Prostatic Neoplasms / metabolism
• Reactive Oxygen Species / analysis*
• Reactive Oxygen Species / metabolism
• Time Factors
• Umbilical Veins / cytology